Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter
- 15 October 2004
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 37 (8), 1231-1243
- https://doi.org/10.1016/j.freeradbiomed.2004.06.042
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Disruption of Dihydronicotinamide Riboside:Quinone Oxidoreductase 2 (NQO2) Leads to Myeloid Hyperplasia of Bone Marrow and Decreased Sensitivity to Menadione ToxicityPublished by Elsevier ,2002
- Sp3 Represses Gene Expression via the Titration of Promoter-specific Transcription FactorsPublished by Elsevier ,2002
- An Association between Idiopathic Parkinson's Disease and Polymorphisms of Phase II Detoxification Enzymes: Glutathione S-Transferase M1 and Quinone Oxidoreductase 1 and 2Biochemical and Biophysical Research Communications, 2001
- NRH:quinone oxidoreductase2 (NQO2)Chemico-Biological Interactions, 2000
- Sp3 and Sp4 Can Repress Transcription by Competing with Sp1 for the Core cis-Elements on the Human ADH5/FDHMinimal PromoterPublished by Elsevier ,1999
- Regulation of Mouse Ah Receptor (Ahr) Gene Basal Expression by Members of the Sp Family of Transcription FactorsDNA and Cell Biology, 1998
- The Human POLD1 GeneJournal of Biological Chemistry, 1997
- Sp1 Trans-Activation of Cell Cycle Regulated Promoters Is Selectively Repressed by Sp3Biochemistry, 1995
- Multiple specific contacts between a mammalian transcription factor and its cognate promotersNature, 1984
- Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase IICell, 1983